Science Signalling News Today : Breaking News, Live Updates & Top Stories | Vimarsana

2020 2016 2014 2014 2013 2013 2012 Presenilin-null cells have altered two-pore calcium channel expression and lysosomal calcium: implications for lysosomal function, Brain Research 2012 The Probability of Triggering Calcium Puffs Is Linearly Related to the Number of Inositol Trisphosphate Receptors in a Cluster, Biophysical Journal 2011 Transient receptor potential mucolipin 1 (TRPML1) and two-pore channels are functionally independent organellar ion channels, Journal of Bio...

This new study will help scientists in the development of new drugs for treating COVID-19. Feb 15, 2021 10:29:33 IST Scientists, including one of Indian-origin, have identified parts of human proteins which the novel coronavirus could be using to hijack host cell processes, an advance that may lead to the development of new drugs for treating COVID-19. The researchers, including Manjeet Kumar from the European Molecular Biology Laboratory (EMBL) in Germany, analysed the chain of amino acid molecules that makes up the human proteins involved in the coronavirus infection, such as a class of pro...

PTI | Berlin | Updated: 13-02-2021 13:05 IST | Created: 13-02-2021 12:41 IST Representative Image. Image Credit: Pixabay Scientists, including one of Indian-origin, have identified parts of human proteins which the novel coronavirus could be using to hijack host cell processes, an advance that may lead to the development of new drugs for treating COVID-19. The researchers, including Manjeet Kumar from the European Molecular Biology Laboratory (EMBL) in Germany, analysed the chain of amino acid molecules that makes up the human proteins involved in the coronavirus infection, such as a class ...

Scientists, including one of Indian-origin, have identified parts of human proteins which the novel coronavirus could be using to hijack host cell processes, an advance that may lead to the development of new drugs for treating Covid-19. The researchers, including Manjeet Kumar from the European Molecular Biology Laboratory (EMBL) in Germany, analysed the chain of amino acid